MAPK3 and Huntington disease: Activation of ERK-mediated mitochondrial Drp1 phosphorylation at S616 promotes chemotherapy resistance in colorectal cancer31 and inhibition of p-ERK1/2 by U0126 suppresses mitochondrial fission by decreasing Drp1 phosphorylation at S616 in Huntington’s disease mutant cells32.